4//SEC Filing
Murphy Michael R 4
Accession 0001312548-12-000045
CIK 0001323885other
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 5:36 PM ET
Size
12.5 KB
Accession
0001312548-12-000045
Insider Transaction Report
Form 4
AtriCure, Inc.ATRC
Discovery Group I, LLC
10% Owner
Transactions
- Sale
Common Stock
2012-12-03$6.71/sh−1,500$10,069→ 232,580 total(indirect: By Pleiades Investment Partners - D, L.P) - Sale
Common Stock
2012-11-30$6.81/sh−1,000$6,811→ 234,080 total(indirect: By Pleiades Investment Partners - D, L.P) - Sale
Common Stock
2012-12-04$6.50/sh−29,700$193,050→ 202,880 total(indirect: By Pleiades Investment Partners - D, L.P)
Donoghue Daniel J
10% Owner
Transactions
- Sale
Common Stock
2012-12-03$6.71/sh−1,500$10,069→ 232,580 total(indirect: By Pleiades Investment Partners - D, L.P) - Sale
Common Stock
2012-11-30$6.81/sh−1,000$6,811→ 234,080 total(indirect: By Pleiades Investment Partners - D, L.P) - Sale
Common Stock
2012-12-04$6.50/sh−29,700$193,050→ 202,880 total(indirect: By Pleiades Investment Partners - D, L.P)
Murphy Michael R
10% Owner
Transactions
- Sale
Common Stock
2012-11-30$6.81/sh−1,000$6,811→ 234,080 total(indirect: By Pleiades Investment Partners - D, L.P) - Sale
Common Stock
2012-12-04$6.50/sh−29,700$193,050→ 202,880 total(indirect: By Pleiades Investment Partners - D, L.P) - Sale
Common Stock
2012-12-03$6.71/sh−1,500$10,069→ 232,580 total(indirect: By Pleiades Investment Partners - D, L.P)
Footnotes (3)
- [F1]Discovery Group I, LLC is an investment manager for Pleiades Investment Partners - D, L.P., which is a discretionary client of the reporting person, that owns the reported securities. The reporting person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.
- [F2]This transaction was executed in multiple trades at prices ranging from $6.75-$6.9250. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected
- [F3]This transaction was executed in multiple trades at prices ranging from $6.7050 - $6.75. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected
Documents
Issuer
AtriCure, Inc.
CIK 0001323885
Entity typeother
Related Parties
1- filerCIK 0001323510
Filing Metadata
- Form type
- 4
- Filed
- Dec 3, 7:00 PM ET
- Accepted
- Dec 4, 5:36 PM ET
- Size
- 12.5 KB